Suppr超能文献

精准肿瘤学时代肺癌预后沟通:多视角定性研究。

Prognostic communication about lung cancer in the precision oncology era: A multiple-perspective qualitative study.

机构信息

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

EGFR Resisters, Deerfield, Illinois, USA.

出版信息

Cancer. 2022 Aug 15;128(16):3120-3128. doi: 10.1002/cncr.34369. Epub 2022 Jun 22.

Abstract

BACKGROUND

Although most patients with cancer prefer to know their prognosis, prognostic communication between oncologists and patients is often insufficient. Targeted therapies for lung cancer improve survival yet are not curative and produce variable responses. This study sought to describe how oncologists communicate about prognosis with patients receiving targeted therapies for lung cancer.

METHODS

This qualitative study included 39 patients with advanced lung cancer with targetable mutations, 14 caregivers, and 10 oncologists. Semistructured interviews with patients and caregivers and focus groups or interviews with oncologists were conducted to explore their experiences with prognostic communication. One oncology follow-up visit was audio-recorded per patient. A framework approach was used to analyze interview transcripts, and a content analysis of patient-oncologist dialogue was conducted. Themes were identified within each source and then integrated across sources to create a multidimensional description of prognostic communication.

RESULTS

Six themes in prognostic communication were identified: Patients with targetable mutations develop a distinct identity in the lung cancer community that affects their information-seeking and self-advocacy; oncologists set high expectations for targeted therapy; the uncertain availability of new therapies complicates prognostic discussions; patients and caregivers have variable information preferences; patients raise questions about progression by asking about physical symptoms or scan results; and patients' expectations of targeted therapy influence their medical decision-making.

CONCLUSIONS

Optimistic patient-oncologist communication shapes the expectations of patients receiving targeted therapy for lung cancer and affects their decision-making. Further research and clinical guidance are needed to help oncologists to communicate uncertain outcomes effectively.

摘要

背景

尽管大多数癌症患者都希望了解自己的预后,但肿瘤医生与患者之间的预后沟通往往不够充分。肺癌的靶向治疗可改善生存,但无法治愈且疗效存在差异。本研究旨在描述肺癌靶向治疗患者的肿瘤医生如何进行预后沟通。

方法

本研究为一项定性研究,纳入了 39 名携带可靶向突变的晚期肺癌患者、14 名护理人员和 10 名肿瘤医生。对患者和护理人员进行半结构化访谈,对肿瘤医生进行焦点小组访谈或个别访谈,以探讨他们在预后沟通方面的经验。每位患者随访时会进行一次音频记录。采用框架方法分析访谈记录,并对医患对话进行内容分析。在每个来源中确定主题,然后整合跨来源的信息以创建预后沟通的多维描述。

结果

确定了预后沟通中的 6 个主题:携带可靶向突变的患者在肺癌患者群体中形成了独特的身份认同,这影响了他们的信息寻求和自我倡导;肿瘤医生对靶向治疗寄予厚望;新疗法的不确定性使预后讨论变得复杂;患者和护理人员的信息偏好存在差异;患者通过询问身体症状或扫描结果来询问疾病进展情况;以及患者对靶向治疗的期望影响他们的医疗决策。

结论

乐观的医患沟通塑造了接受肺癌靶向治疗患者的期望,并影响了他们的决策。需要进一步的研究和临床指导,以帮助肿瘤医生有效地沟通不确定的结局。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验